MENU
+Compare
ABOS
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$1.65
Change
+$0.04 (+2.48%)
Capitalization
99.13M

ABOS Acumen Pharmaceuticals Forecast, Technical & Fundamental Analysis

Industry Biotechnology
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ABOS with price predictions
Jan 08, 2025

ABOS's Indicator enters downward trend

The Aroon Indicator for ABOS entered a downward trend on January 08, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 218 similar instances where the Aroon Indicator formed such a pattern. In of the 218 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 07, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ABOS as a result. In of 59 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABOS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ABOS's RSI Oscillator exited the oversold zone, of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 41 cases where ABOS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ABOS just turned positive on January 02, 2025. Looking at past instances where ABOS's MACD turned positive, the stock continued to rise in of 27 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ABOS advanced for three days, in of 187 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.456) is normal, around the industry mean (14.746). P/E Ratio (0.000) is within average values for comparable stocks, (88.252). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.853). ABOS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (264.084).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ABOS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ABOS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ABOS is expected to report earnings to fall 7.76% to -46 cents per share on March 31

Acumen Pharmaceuticals ABOS Stock Earnings Reports
Q4'24
Est.
$-0.46
Q3'24
Missed
by $0.14
Q2'24
Missed
by $0.07
Q1'24
Beat
by $0.01
Q4'23
Missed
by $0.11
The last earnings report on November 12 showed earnings per share of -50 cents, missing the estimate of -36 cents. With 547.08K shares outstanding, the current market capitalization sits at 99.13M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
427 Park Street
Phone
+1 434 297-1000
Employees
52
Web
https://www.acumenpharm.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SNNAF0.02N/A
+10.06%
SIENNA RESOURCES INC
DIDIY4.700.09
+1.95%
DiDi Global Inc.
MRMD0.12N/A
+1.77%
MariMed Inc.
BASFY11.360.03
+0.26%
BASF SE
MZDAY3.24N/A
N/A
Mazda Motor Corp.

ABOS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with MGTX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
+2.48%
MGTX - ABOS
48%
Loosely correlated
+5.56%
AURA - ABOS
48%
Loosely correlated
+1.30%
ABCL - ABOS
47%
Loosely correlated
+1.02%
GBIO - ABOS
47%
Loosely correlated
+0.18%
BEAM - ABOS
46%
Loosely correlated
+0.17%
More